# Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects

> **NCT00928135** · PHASE1,PHASE2 · COMPLETED · sponsor: **Joseph Zabner** · enrollment: 63 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Xylitol
- **DRUG:** Hypertonic saline

## Key facts

- **NCT ID:** NCT00928135
- **Lead sponsor:** Joseph Zabner
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-22
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-04-09
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928135, "Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00928135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*